Type 2 & other diabetes

Weight variability and cardiovascular outcomes: a systematic review and meta-analysis

Cardiovasc DiabetolPublished Systematic review and meta-analysis of observational studies

Authors' conclusion

In conclusion, body weight variability is associated with increased risk of CV diseases regardless of ethnicity or diabetes status.

Study context

Population
Studies of body weight or BMI variability and cardiovascular disease (CVD); PubMed, Web of Science, Cochrane Library
Participants
15,382,537 participants23 studies
Comparison
Highest vs lower strata of body weight variability
Outcome
Risk of CVD: any cardiovascular (CV) event, composite CV outcome, CV death, stroke, MI
Methodological detailsMOOSE guidelines, random-effects model, 5645 articles screened
  • MOOSE guidelines
  • Random-effects model
  • 5645 articles screened

Pooled result

As reported in the abstract

CVD outcomes, highest strata of body weight variability
Highest weight variabilityEstimate (95% CI)P value
I2 = 97.28%
RR, any CV event 1.27(1.17–1.38)
P < 0.0001
I2 = 55.16%
RR, CV death 1.29(1.03–1.60)
P < 0.0001
I2 = 97.14%
RR, MI 1.32(1.09–1.59)
P = 0.0037
I2 = 0.06%
RR, stroke 1.21(1.19–1.24)
P < 0.0001
I2 = 92.41%
RR, compound CVD outcomes 1.36(1.08–1.73)
P = 0.01

Further pooled results

BMI variability and per unit SD increase in body weight variability

Similar relative risks (RRs) observed

Subgroups by diabetes status and ethnicity

Comparable effects in people with and without diabetes, in White Europeans and Asians

Original publication

Weight variability and cardiovascular outcomes: a systematic review and meta-analysis. Cardiovasc Diabetol. Published 9 January 2023. doi:10.1186/s12933-022-01735-x

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.